Biotech · Private company
Walden Biosciences
Track this companyFree. Adds Walden Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- WAL0921Phase 2 · Diabetic NephropathiesClinicalTrials.gov · fetched Nov 12, 2026
- WAL0921Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of WAL0921 in Patients With Glomerular Kidney DiseasesPHASE2 · RECRUITING · started Jul 2, 2024ClinicalTrials.gov NCT06466135 · fetched Nov 12, 2026
- Single Ascending Dose Study of WAL0921 in Healthy SubjectsPHASE1 · COMPLETED · started May 31, 2023ClinicalTrials.gov NCT05891366 · fetched Nov 12, 2026